在生物制造应用中,在Vibrio natriegens中引入工程酶
Eric VanArsdale1, Erin Kelly2, Cameron V Sayer2
1National Research Council, United States Naval Research Laboratory, Washington, District of Columbia, USA.
Biotechnology and bioengineering
|July 20, 2024
概括
在Vibrio natriegens中进行的工程化酶诱导使得使用可再生原料,如海藻等可扩展的生物生产成为可能. 这种具有成本效益的方法优化了有价值产品的定时生物合成.
科学领域:
- 微生物学 微生物学
- 合成生物学 合成生物学
- 生物技术是生物技术.
背景情况:
- 克西洛斯是一种丰富,廉价的碳水化合物,存在于可再生原料中,如海藻和藻类.
- 维布里奥纳特里根菌是一种快速生长的,适合生物生产的,格拉姆阴性型细菌.
- 有限的微生物底盘存在,具有必要的遗传工具来利用未充分利用的原料.
研究的目的:
- 为可扩展的生物生产设计和测试Vibrio natriegens中的酶诱导.
- 为了优化V. natriegens. 的酶诱导基因表达.
- 用工程V. natriegens和海藻衍生的诱导剂来证明黑色素的产生.
主要方法:
- 使用大肠杆菌的氧化操作子和光记者构建了一个可诱导氧化的传感系统.
- 研究了细胞进口和XylR转录因子在酶诱导中的作用.
- 修改后的促进子区域以增强基因表达并减轻碳水化合物抑制.
- 使用工程V. natriegens与海藻提取物作为诱导剂生产的黑色素.
主要成果:
- 细胞进口和XylR转录因子对于克西洛斯诱导强度至关重要.
- 在促进子区域的删除改善了基因表达和减少碳水化合物抑制.
- 使用基于的海藻提取物诱导剂,获得了与传统方法相似的黑色素生产产量.
- 证明了使用可再生,低成本诱导剂用于生物制造的可行性.
结论:
- 在V. natriegens中,工程化酶诱导为定时生物合成提供了一种有效和经济的工具.
- 这种方法支持使用可再生原料进行可扩展的生物制造.
- 优化V. natriegens菌株为可持续生物生产提供了一个有希望的底盘.
相关概念视频
01:25Microbes in Beverage Production
241
Alcoholic beverages such as wine, beer, and spirits are the products of microbial fermentation processes that transform simple sugars into ethanol and a wide array of complex flavor compounds. These transformations rely on the metabolic activities of specific yeasts and bacteria, which are selected and controlled to yield the desired beverage characteristics.Wine Fermentation and MaturationWine production begins with the crushing of grapes to release juice and pulp, forming a must that is...
241
01:22Bioreactor Controls-III
54
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
54
01:30Designing Growth Media for Bioreactors
63
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
63
01:27Upstream Processing
81
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
81
01:27Production of Antibiotics
93
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
93
01:30Production of Pharmaceuticals
66
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
66